Literature DB >> 17462458

Repeat hepatectomy for recurrent hepatocellular carcinoma.

Toshiyuki Itamoto1, Hideki Nakahara, Hironobu Amano, Toshihiko Kohashi, Hideki Ohdan, Hirotaka Tashiro, Toshimasa Asahara.   

Abstract

BACKGROUND: Long-term prognosis of patients with hepatocellular carcinoma (HCC) after partial hepatectomy remains unsatisfactory because of the high incidence of recurrence in the liver remnant. Controversy exists about the efficacy of repeat hepatectomy for recurrent HCC patients. The purpose of this study was to retrospectively examine and clarify the significance of repeat hepatectomy in the treatment of recurrent HCC.
METHODS: From January 1990 to December 2004, 84 patients with recurrent HCC underwent a second hepatectomy with curative intent. Survival rates in these 84 patients were analyzed retrospectively.
RESULTS: After the second hepatectomy, the overall 5-year survival rate was 50% for the 84 patients included in this study; the corresponding recurrence-free survival rate was 10%. Multivariate analysis showed that the second hepatectomy performed between 1997 and 2004 (P < .001) and the absence of microscopic vascular invasion at the second hepatectomy (P = .001) were the significant and independent prognostic factors for overall survival after the second hepatectomy. The overall 5-year survival rate after the second hepatectomy was 80% in 46 patients who had both these prognostic factors. However, even in the subgroup with good long-term survival, the 5-year recurrence-free survival rate was only 6%. The more times hepatectomy was repeated, the shorter the recurrence-free interval became.
CONCLUSIONS: Repeat hepatectomy for recurrent HCC had survival benefits, especially for patients without microscopic vascular invasion. However, the incidence of re-recurrence after the second hepatectomy was high, and the recurrence-free interval was short, even in the subgroup with survival benefits. The effectiveness of repeat hepatectomy for curing recurrent HCC is limited.

Entities:  

Mesh:

Year:  2007        PMID: 17462458     DOI: 10.1016/j.surg.2006.12.014

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  42 in total

1.  Impact of Preoperative Hepatitis B Virus Levels on Prognosis After Primary and Repeat Hepatectomies for Hepatocellular Carcinoma Patients-a Retrospective Study.

Authors:  Pin-Gao Yan; Ruo-Yu Wang; Jin Zhang; Wen-Ming Cong; Hui Dong; Hong-Yu Yu; Wan Yee Lau; Meng-Chao Wu; Wei-Ping Zhou
Journal:  J Gastrointest Surg       Date:  2018-01-08       Impact factor: 3.452

2.  Preoperative Predictors Including the Role of Inflammatory Indices in Predicting Early Recurrence After Re-resection for Recurrent Hepatocellular Carcinoma.

Authors:  Yuxin Guo; Darren W Chua; Ye-Xin Koh; Ser-Yee Lee; Peng-Chung Cheow; Juinn-Huar Kam; Jin-Yao Teo; Pierce K Chow; Alexander Y Chung; London L Ooi; Chung-Yip Chan; Brian K P Goh
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

3.  Oncolytic adenovirus SG600-IL24 selectively kills hepatocellular carcinoma cell lines.

Authors:  Xin-Bo Xue; Chao-Wen Xiao; Hui Zhang; Ai-Guo Lu; Wei Gao; Zhu-Qing Zhou; Xin-Lai Guo; Ming-An Zhong; Yao Yang; Cong-Jun Wang
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

4.  Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma.

Authors:  Tomoyuki Abe; Hirotaka Tashiro; Tsuyoshi Kobayashi; Minoru Hattori; Shintaro Kuroda; Hideki Ohdan
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

5.  Significance of platelet count in the outcomes of hepatectomized patients with hepatocellular carcinoma exceeding the Milan criteria.

Authors:  Hironobu Amano; Hirotaka Tashiro; Akihiko Oshita; Tsuyoshi Kobayashi; Yoshisato Tanimoto; Shintaro Kuroda; Hirofumi Tazawa; Toshiyuki Itamoto; Toshimasa Asahara; Hideki Ohdan
Journal:  J Gastrointest Surg       Date:  2011-04-22       Impact factor: 3.452

6.  Pure laparoscopic hepatectomy as repeat surgery and repeat hepatectomy.

Authors:  Masashi Isetani; Zenichi Morise; Norihiko Kawabe; Hirokazu Tomishige; Hidetoshi Nagata; Jin Kawase; Satoshi Arakawa
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

7.  Nomogram predicting long-term survival after the diagnosis of intrahepatic recurrence of hepatocellular carcinoma following an initial liver resection.

Authors:  Tsuyoshi Notake; Akira Kobayashi; Hiroji Shinkawa; Takuya Kawahara; Akira Shimizu; Takahide Yokoyama; Kiyoshi Hasegawa; Norihiro Kokudo; Yutaka Matsuyama; Masatoshi Makuuchi; Shin-Ichi Miyagawa
Journal:  Int J Clin Oncol       Date:  2017-03-16       Impact factor: 3.402

8.  Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.

Authors:  Zhenwei Peng; Mengchao Wei; Shuling Chen; Manxia Lin; Chunlin Jiang; Jie Mei; Bin Li; Yu Wang; Jiaping Li; Xiaoyan Xie; Ming Kuang
Journal:  Eur Radiol       Date:  2018-03-13       Impact factor: 5.315

9.  Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases.

Authors:  Tian Yang; Jin Zhang; Jun-Hua Lu; Guang-Shun Yang; Meng-Chao Wu; Wei-Feng Yu
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

10.  Surgery for Hepatocellular Carcinoma in Patients with Child-Pugh B Cirrhosis: Hepatic Resection Versus Living Donor Liver Transplantation.

Authors:  Norifumi Harimoto; Tomoharu Yoshizumi; Yukiko Fujimoto; Takashi Motomura; Youhei Mano; Takeo Toshima; Shinji Itoh; Noboru Harada; Toru Ikegami; Hideaki Uchiyama; Yuji Soejima; Yoshihiko Maehara
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.